UBS Maintains Buy on Labcorp Holdings, Raises Price Target to $270
Portfolio Pulse from Benzinga Newsdesk
UBS analyst Kevin Caliendo maintains a Buy rating on Labcorp Holdings (NYSE:LH) and raises the price target from $260 to $270.
August 02, 2024 | 5:51 pm
News sentiment analysis
Sort by:
Ascending
POSITIVE IMPACT
UBS analyst Kevin Caliendo maintains a Buy rating on Labcorp Holdings and raises the price target from $260 to $270.
The Buy rating and increased price target from a reputable analyst at UBS is likely to positively influence investor sentiment and drive short-term price appreciation for Labcorp Holdings.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100